ANAB Maintained by JP Morgan -- Price Target Lowered to $60.00

gurufocus.com · 2026-09-30

AnaptysBio (ANAB) Analyst Rating Update On October 03, 2023, JP Morgan maintained an Overweight rating on AnaptysBio (ANAB). However, the firm has lowered it

Read the full story at gurufocus.com →